NUFARM LIMITED — Director's Dealing 2025

Jan 16, 2025

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

��������������������������������������

Name of entity: NUFARM LIMITED

ABN 37 091 323 312

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Gregory Allan Hunt
Date of last notice	19/06/2024

Part 1 ‐ Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct and indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving riseto the relevant interest.	Our Barnyard Pty Ltd as trustee for the GA HuntFamily Trust. Mr Hunt is a beneficiary of the Trustand director of the trustee.CPU Share Plans Pty Ltd as trustee of Nufarm’semployee share plan trust. Shares are held on behalfof Mr Hunt.
Date of change	13/01/2025
No. of securities held prior to change	Direct: 155,889 ordinary sharesDirect: 467,897 Performance Rights comprised of:FY22 284,791 EIP Performance RightsFY23 183,106 EIP Performance RightsIndirect: 878,786 ordinary shares comprised of:Our Barnyard Pty Ltd – 252,677 ordinarysharesCPU Share Plans Pty Ltd – 626,109 ordinaryshares

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Class	Ordinary shares
Number acquired	27 shares by CPU Share Plans Pty Ltd
Number disposed	Nil
Value/Consideration	Market value on issue date of $3.57258 per ordinary
Note: If consideration is non-cash, provide detailsand estimated valuation	share. Nil consideration paid by participants in
	accordance with the Nufarm Global Share Plan
No. of securities held after change	Direct: 155,889 ordinary shares
	Direct: 467,897 Performance Rights comprised of:
	FY22 284,791 EIP Performance Rights
	FY23 183,106 EIP Performance Rights
	Indirect: 878,813 ordinary shares comprised of:
	Our Barnyard Pty Ltd – 252,677 ordinary
	shares
	CPU Share Plans Pty Ltd – 626,136 ordinary
	shares
Nature of change	Issue of securities under Global Share Plan
Example: on-market trade, off-market trade, exercise
of options, issue of securities under dividend
reinvestment plan, participation in buy-back

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder
(if issued securities)
Date of change
No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required?	Were the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required?	no	no
If so, was prior written clearance providetrade to proceed during this period?	d to allow the
If prior written clearance was provided, onthis provided?	what date was

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 3